These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27725124)

  • 21. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased serum levels of sCD40L and IL-31 correlate in treated patients with Relapsing-Remitting Multiple Sclerosis.
    de J Guerrero-García J; Rojas-Mayorquín AE; Valle Y; Padilla-Gutiérrez JR; Castañeda-Moreno VA; Mireles-Ramírez MA; Muñoz-Valle JF; Ortuño-Sahagún D
    Immunobiology; 2018 Jan; 223(1):135-141. PubMed ID: 29050818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica.
    Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A
    Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
    Harirchian MH; Tafakhori A; Taslimi S; Aghamollaii V; Shahsiah R; Gholipour T; Mohammadi F; Zare-Shahabadi A
    Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):98-104. PubMed ID: 25530145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivity to AQP4 epitopes in relapsing-remitting multiple sclerosis.
    Alexopoulos H; Kampylafka EI; Chatzi I; Travasarou M; Karageorgiou KE; Dalakas MC; Tzioufas AG
    J Neuroimmunol; 2013 Jul; 260(1-2):117-20. PubMed ID: 23673145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
    Karussis D
    J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement activation in patients with neuromyelitis optica.
    Nytrova P; Potlukova E; Kemlink D; Woodhall M; Horakova D; Waters P; Havrdova E; Zivorova D; Vincent A; Trendelenburg M
    J Neuroimmunol; 2014 Sep; 274(1-2):185-91. PubMed ID: 25109258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
    Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
    J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromyelitis optica preceded by hyperCKemia episode.
    Jeret JS; Suzuki N; Takahashi T; Fujihara K
    Neurology; 2010 Dec; 75(24):2253 author reply 2253-4. PubMed ID: 21172851
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neuromyelitis optica: a clinical update].
    Chiquete E; Navarro-Bonnet J; Ayala-Armas R; Gutiérrez-Gutiérrez N; Solórzano-Meléndez A; Rodríguez-Tapia D; Gómez-Rincón M; Ruiz-Sandoval JL
    Rev Neurol; 2010 Sep; 51(5):289-94. PubMed ID: 20669128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
    Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
    J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromyelitis optica preceded by brain demyelinating episode.
    Amemiya S; Hamamoto M; Kumagai T; Ueda M; Katayama Y; Tanaka K
    J Neuroimaging; 2009 Jul; 19(3):263-5. PubMed ID: 18681925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases.
    Sharaf-Eldin WE; Kishk NA; Gad YZ; Hassan H; Ali MAM; Zaki MS; Mohamed MR; Essawi ML
    J Neurol Sci; 2017 Dec; 383():188-198. PubMed ID: 29246612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
    Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
    J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
    Papais-Alvarenga RM; Vasconcelos CC; Alves-Leon SV; Batista E; Santos CM; Camargo SM; Godoy M; Lacativa MC; Lorenti M; Damasceno B; Damasceno A; Brum D; Barreira AA; Guimarães Rocha MS; Alvarenga H; Tilbery CP
    Mult Scler; 2014 Mar; 20(3):374-81. PubMed ID: 23970504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
    Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
    Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
    Wang H; Wang K; Xu W; Wang C; Qiu W; Zhong X; Dai Y; Wu A; Hu X
    J Neurochem; 2012 Jul; 122(1):19-23. PubMed ID: 22469018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis.
    Uzawa A; Mori M; Hayakawa S; Masuda S; Kuwabara S
    Eur J Neurol; 2010 May; 17(5):672-6. PubMed ID: 20039942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
    Quan C; Yu H; Qiao J; Xiao B; Zhao G; Wu Z; Li Z; Lu C
    Mult Scler; 2013 Mar; 19(3):289-98. PubMed ID: 22864301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.